These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7447418)

  • 1. Comparison of ceforanide, cefazolin, methicillin, and nafcillin in Staphylococcus aureus endocarditis therapy in rabbits.
    Carrizosa J; Kobasa WD; Kaye D
    Antimicrob Agents Chemother; 1980 Oct; 18(4):562-5. PubMed ID: 7447418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of experimental Staphylococcus aureus endocarditis: comparison of cephalothin, cefazolin, and methicillin.
    Carrizosa J; Santoro J; Kaye D
    Antimicrob Agents Chemother; 1978 Jan; 13(1):74-7. PubMed ID: 626493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of nafcillin, methicillin, and cephalothin in experimental Staphylococcus aureus endocarditis.
    Carrizosa J; Kobasa WD; Kaye D
    Antimicrob Agents Chemother; 1979 May; 15(5):735-7. PubMed ID: 525991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of methicillin, nafcillin, and oxacillin in therapy of Staphylococcus aureus endocarditis in rabbits.
    Egert J; Carrizosa J; Kaye D; Kobasa WD
    J Lab Clin Med; 1977 Jun; 89(6):1262-8. PubMed ID: 864305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefoperazone treatment of experimental endocarditis.
    Snepar RA; Carrizosa J; Kobasa WD; Kaye D
    Antimicrob Agents Chemother; 1981 May; 19(5):773-6. PubMed ID: 6457556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory tests for defining bactericidal activity as predictors of antibiotic efficacy in the treatment of endocarditis due to Staphylococcus aureus in rabbits.
    Fass RJ
    J Infect Dis; 1984 Jun; 149(6):904-12. PubMed ID: 6736681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus.
    Chambers HF; Sande MA
    Antimicrob Agents Chemother; 1984 Jul; 26(1):61-4. PubMed ID: 6236747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of safety and outcomes with cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bloodstream infections.
    Miller MA; Fish DN; Barber GR; Barron MA; Goolsby TA; Moine P; Mueller SW
    J Microbiol Immunol Infect; 2020 Apr; 53(2):321-327. PubMed ID: 30190234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial prophylaxis of experimental endocarditis caused by Staphylococcus epidermidis.
    Baddour LM; Hill MM; Felty-Duckworth AM
    Infection; 1989; 17(2):90-6. PubMed ID: 2714864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methicillin-Susceptible Staphylococcus Aureus Bacteremia: Cefazolin in Prime But Nafcillin Not Ready for an Exit.
    Sarria JC
    Am J Med Sci; 2020 Jul; 360(1):3-4. PubMed ID: 32439151
    [No Abstract]   [Full Text] [Related]  

  • 11. Relative efficacies of broad-spectrum cephalosporins for treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditis.
    Steckelberg JM; Rouse MS; Tallan BM; Osmon DR; Henry NK; Wilson WR
    Antimicrob Agents Chemother; 1993 Mar; 37(3):554-8. PubMed ID: 8460924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefazolin versus Nafcillin for Methicillin-Sensitive Staphylococcus aureus Bloodstream Infection in a California Tertiary Medical Center.
    Pollett S; Baxi SM; Rutherford GW; Doernberg SB; Bacchetti P; Chambers HF
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4684-9. PubMed ID: 27216053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Ceftaroline against Methicillin-Susceptible Staphylococcus aureus Exhibiting the Cefazolin High-Inoculum Effect in a Rat Model of Endocarditis.
    Singh KV; Tran TT; Nannini EC; Tam VH; Arias CA; Murray BE
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.
    Sande MA; Courtney KB
    J Lab Clin Med; 1976 Jul; 88(1):118-24. PubMed ID: 1047088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic therapy of experimental Staphylococcus epidermidis endocarditis.
    Vazquez GJ; Archer GL
    Antimicrob Agents Chemother; 1980 Feb; 17(2):280-5. PubMed ID: 7387148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unsuccessful treatment of staphylococcal endocarditis with cefazolin.
    Bryant RE; Alford RH
    JAMA; 1977 Feb; 237(6):569-70. PubMed ID: 576284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cefazolin, cefamandole, vancomycin, and LY146032 for prophylaxis of experimental Staphylococcus epidermidis endocarditis.
    Wheat LJ; Smith JW; Reynolds J; Bemis AT; Treger T; Norton JA
    Antimicrob Agents Chemother; 1988 Jan; 32(1):63-7. PubMed ID: 2831815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of ceforanide as treatment for staphylococcal and streptococcal endocarditis.
    Cooper RH; Savitch CB; Joseph WP; Mills J
    Antimicrob Agents Chemother; 1981 Feb; 19(2):256-9. PubMed ID: 7347561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective Analysis of Adverse Drug Events Between Nafcillin Versus Cefazolin for Treatment of Methicillin-Susceptible
    Chan L; Chan-Tompkins NH; Como J; Guarascio AJ
    Ann Pharmacother; 2020 Jul; 54(7):662-668. PubMed ID: 31888347
    [No Abstract]   [Full Text] [Related]  

  • 20. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus.
    Fernandez-Guerrero M; Rouse M; Henry N; Wilson W
    Antimicrob Agents Chemother; 1988 May; 32(5):747-51. PubMed ID: 3164989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.